Therapeutic Products Bill Hikoi

Here are the photographs captured during the Hikoi event that took place last Wednesday.
Included is the completed open letter, accompanied by 73 logos, which exemplifies a remarkable collective endeavour that conveyed a clear message to the Government.
At present, we are anticipating the release of the report from the Health Select Committee, expected to be presented in the House this Wednesday.


Warmest congratulations to Dr Ruth Spearing CNZM

Dr Ruth Spearing, a distinguished haematologist and medical researcher with a strong interest in CLL, has been made a Companion of the New Zealand Order of Merit for services to haematology in the King’s Birthday Honours.

Dr Ruth Spearing has been a consultant haematologist and taken a lead nationally in haematology trials. She was involved in setting up the partnership with the UK Medical Research Haematology Trials group which New Zealand joined in 1989. As well as many other clinical trials, she is the New Zealand Principle Investigator for the UK MRC Acute Myeloid Leukaemia trails which have has seen an improvement in survival in this condition from 2% to 56%. The outcomes are now as good as if not better than other countries.  She was the New Zealand Principal Investigator for the UK MRC myeloma VII trial which was published in the New England Journal of Medicine and which established autologous (self) stem cell transplantation as part of the upfront treatment of myeloma.

She has a particular interest in adolescents and young adults and is the Canterbury Clinical Lead for the Adolescent and Young Adult Cancer Service and on the National Adolescent and Young Adult Cancer Governance Group. She has also had various leadership roles being a Board Member of the New Zealand Medical Association, an elected member of the Canterbury District Health Board Clinical Board and Chair of the Canterbury Hospitals Medical Staff Association.

Looking after Barry Mather was a privilege as he was obviously such a fabulous and generous man. He was aware that only with research will there be any meaningful advances. It is very satisfying to see that money that Barry has donated has gone to towards research into the condition that he had, Chronic Lymphocytic Leukaemia, and also to enable the setting up of a Clinical Haematology Research Unit down in Dunedin which now is progressing well with its own funding.

See RNZ’s interview here: Kings-birthday-honours-Ruth-Spearing

Haematologist Dr Ruth Spearing said being made a Companion of the New Zealand Order of Merit for her services to haematology was a "huge" honour and surprise.

"I'd like to think that I'm actually accepting this on behalf of all the haematologists in the country," she said.

Spearing has led internationally recognised research into blood cancers for more than 30 years, and the Ruth Spearing Cancer Research Trust was established in 2008, which supported South Island haematology research.

Spearing said a career highlight had been persuading Pharmac to fund a drug which enabled New Zealand to be part of a recent trial.

"We managed to persuade them that they needed to bend their rules and as a result of them bending their rules and enabling us to purchase a drug at a greatly reduced cost outside of their usual rules, it resulted in us getting the best ever results.

"Persuading Pharmac to do that is probably my career highlight."


CLL Advocates June Newsletter

Dear Friends of CLL Advocates

 

We have a lot to report on and a lot to get on with!

 

CLL Focus groups

We’re pleased to share an overview of key findings from the CLL patient focus group discussions we held in December 2022 (Focus Groups Research – CLL Advocates NZ)

It highlights the major themes and issues that emerged from the research and sets out priority areas of focus for CLLANZ. Get in touch if you’d like to help with these! Meanwhile we’re working with the facilitator of the focus groups to follow up on her recommendation that we survey a wider group of patients and carers.

Local support groups for CLL patients

Another action arising from the focus groups is the need for local support groups.

Are you interested in joining or starting one in your region?

Please contact Diane Ward: dianew564@gmail.com to find out more about this initiative.

The FixRx Buyers Club

We’re currently checking out this buyers’ club that helps patients across the world access authentic medications at affordable cost. If you have any experience of this or are interested in the concept let us know: FixRx Buyers Club

‘Fabulous ladies in the same boat’

Read this great story about three women who met online through being in the same boat - living with CLL. Despite different ages and lives, the three have supported each and become great friends while sharing and navigating the challenges of CLL: Fabulous ladies in the same boat

CLL Advocates Give a Little page

Please help support our mission. No matter how small, your donation will help us advocate for better treatments for CLL and improve the lives of those living with this disease.

Thanks to those who’ve already made donations: CLL Advocates Give a Little Page

Frequently asked questions

A recent update to the "About CLL" section on the webpage includes section that answers common questions about CLL: Frequently asked questions

It also includes a list of questions patients can ask their doctors to better understand their diagnosis and treatment options. Questions for your doctor

Please send any feedback to trustees@clladvocates.org

Best wishes

The Trustees

CLL Advocates NZ


New Zealand's Medicines Landscape 2022/23

Medicines New Zealand has today released the 2022/23 edition of their annual publication New Zealand’s Medicines Landscape. This edition sheds light on the significant cost of ill health to New Zealand and reiterates that New Zealand continues to rank last among the OECD countries for access to modern medicines.

A new report cited in the Landscape shows that New Zealand is in last place amongst OECD countries, with Hungary second to last, in terms of public health system access to modern medicines. New Zealand continues to lag well behind countries like Australia and the UK.

"New Zealand likes to compare itself to Australia and hopes to be better than them. It appears we need to lower our expectations when it comes to modern medicines access- so it's a case of ‘Goodbye Australia - Hello Hungary’ for us and our Health system’s access to modern medicines" says Dr Graeme Jarvis, CEO of Medicines New Zealand.

The Landscape also highlights that the over 80 medicines on Pharmac’s Options for Investment list remain in a state of limbo, for more than five years and counting on average, as they still wait for a funding decision to be made. This is despite the current Government providing some much-needed additional investment to help try and clear the list of medicines - many of which are standard of care in other OECD countries. This creates issues in New Zealand with inequity of access for patients, the health system, broader society and the economy. The country is therefore missing out on the benefits that the medicines could bring.

"It is well established that medicines play a critical role in any health system, allow patients and carers to go back to work and help reduce hospitalisation which may help relieve some of the hospital workforce issues. So it is somewhat surprising that they are not better valued as a critical tool within the health system and society here in New Zealand."

The Landscape also highlights solutions that could allow New Zealand to catch up with our peer OECD nations including the need for the development of a fit-for-purpose, future focussed Medicines Strategy. The need for a Medicines Strategy to be developed by February 2023 was also a recommendation from the Independent Pharmac Review Panel's final report. However, there is no sign of that Strategy being developed at all. Instead, the country is still waiting for it, just like it is for the many medicines on the waiting lists.

The 2022/23 edition of New Zealand’s Medicines Landscape can be found online here.

The PhRMA Report: Global Access to New Medicines Report can be found online here

 


NZ’s Shameful Health Secret

New Zealand sits at the bottom of the western world for access to modern medicines. Pharmac decide what drugs we buy and when. So why aren’t Kiwis getting the medicines they need?

Listen to Rachel Smalley discuss this topic: Rachel Smalley. NZ’s Shameful Health Secret


Understanding the Importance of Screening for Skin Cancer While Living with CLL/SLL

Most individuals with CLL/SLL understand that the compromised immune system is the reason that an increased infection risk comes along with having the disease. But not as many are aware that secondary cancers, such as skin cancer, is also caused by an immune system that is no longer functioning at its best.

Read more here: Screening for Skin Cancer While Living with CLL/SLL


Time taken for Pharmac funding decisions ‘too long’, says Medicines NZ

It takes the nation's drug-buying agency, Pharmac, an average of 7.7 years to make funding decisions about potentially life-saving medicines, a report has found.

The Pharmac's Medicines Waiting Lists: Impacts on Patients in Aotearoa New Zealand report, commissioned by lobby group Medicines New Zealand found it took on an average nearly eight years to reach a decision on applications across all Pharmac lists.

Read the Stuff article here: Pharmac medicines waiting lists too long

Here is the full report: Pharmac Waiting Lists Report April 2023


Cancer patients harmed by ongoing treatment delays at Southern health board

In the first two months of 2021, 27 patients were harmed by cancer treatment delays, the Otago Daily Times reported.

Three became so sick while waiting they were unfit for treatment.

Have you been affected? Please email: newsdesk@nzherald.co.nz 

Please read more here: Cancer patients harmed by treatment delays

 


“Fabulous Ladies in the Same Boat”

These are the stories of three Fabulous Ladies, Wendy, Bronwyn and Diane, all in the same boat.

Thank you and we appreciate you sharing your tales with us.

First we would like to pay tribute to the great work that Dr Neil Graham did on our behalf. He was also a mentor and an encouraging voice to so many of us.

Wendy
I’m Wendy and I’m 72. I was diagnosed with CLL 15 years ago. Until about 3 years ago my CLL had travelled through life never interrupting my work and play.  Fortunately for me in September 2019 Bronwyn , Diane and I connected through the CLL website.  We got chatting privately and somehow the same boat was launched.

In this time, we’ve sailed through calm waters, and we’ve weathered storms together. We are three very different women leading very different lifestyles, but we have this common thread.  We have somehow found some common themes, such as: the disease doesn’t define who we are; one of us will have the wisdom or information that will solve an issue (like where to get ibrutinib from, at an affordable price), and we’re here for you - you’re not alone.

We share with each other how we’re getting on with life. Diane and Bronny truly inspire me, I don’t have enough words to thank them. We are not in constant contact but we each know that when there’s a challenge, medical or personal, the other two are only a message away. Due to Covid we’ve not had a chance for all three to join together, but one day soon. And that’s when we’ll drink our Moët across our trusty little boat’s stern.

 

Bronwyn

In April 2019 I was diagnosed with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukaemia at 46. Mine was an accidental discovery, a total shock. Once I got over my initial shock I wanted to know everything I could about my disease and possible outcomes and treatments. This is when I joined the CLL group. Neil Graham also reached out and chatting to him helped my understanding enormously. I'm not sure who got hold of who, but Wendy and I started privately messaging each other after seeing comments on the CLL page. Very shortly afterwards we started chatting to Diane as well. I then decided we should all chat at the same time and set up a Facebook messenger group called ‘fabulous ladies in the same boat’.

I was working full time in the Air Force when diagnosed and had one child still in the nest. Wendy and Diane are considerably older than me, but that didn't matter at all, we all had CLL. Our experience with the disease over the last few years has been very different, so sharing has been helpful. For example, Wendy and I are on ibrutinib, and Diane is on watch and wait. Sourcing ibrutinib for an affordable price is something Diane helped Wendy with extensively, so when I was making decisions later on, the leg work had already been done. Wendy got hold of me when she was in Auckland back in 2020 and suggested we catch up. I was keen to meet the person I had been talking with a lot at the time, and we got along famously.

Meanwhile Diane and I had established that she had taught with my Dad at Aka Aka School - two degrees of separation in NZ. Wendy and Diane managed to have a weekend together but unfortunately due to Covid and life, the three of us haven't been together in the same place yet. Finally, Diane and I met in person in March last year when she was on a road trip up North, it was like we knew each other already, it was lovely to see her.

Wendy, Diane, and I didn't only share our CLL stories we shared our life stories and became friends. They were there for me over the most stressful time, initial diagnosis, they understood my fear and emotions more than family and friends. I am very thankful for the connection we made and would encourage others to do the same.

 

Diane

And I am Diane. I was diagnosed four years ago at 72. My WBC and ALCs are much higher than my other shipmates have ever been I think (sitting at around 83.5 WBC right now), but I keep really  good health with none of the accompanying symptoms as yet. I get tired from time to time but definitely wouldn’t call it fatigue (probably just old age!)  I take a keen interest in this damned disease we have and the most recent developments in treatment. I use Health Unlocked and Patient Power to helpme  and any other authentic sites I can to stay as informed as I can. I am so hoping that I can hold out until the drugs that are readily available in most developed countries are accessible here in NZ.

I am concerned that our most avid advocate Neil Graham is not with us anymore. We ‘fabulous ladies in the same boat’ would never have met if it hadn’t been for him.

Interestingly we have all made significant lifestyle changes since we met. It was great to meet up in ‘real life’ with Wendy and her partner Graham when they came to Nelson (I think they have since moved in together). I have moved from Nelson to Christchurch to be closer to family, and Bronny. has left the Air Force and moved to a beautiful lifestyle block in Kerikeri with her partner Scott. I am not sure what relevance that has to us all having CLL but maybe it means that we are all on the same path and trying to make the most of life!

 

At the beginning when we were all trying to ‘keep our heads above water ‘ with our new diagnoses we supported each other. Now that we have come to terms with our condition and know more about it we are not so reliant but know that we are always there for each other.

And as Wendy said, ‘One day we will all meet together and share that Moët!’

 


Pharmac's year in review leaves much to be desired

It shouldn’t be this hard when it comes to getting medicines funded. Such efforts highlight everything that is wrong with Pharmac and the way it is funded by the Government.

Patient advocate Malcolm Mulholland hopes health reforms will ensure greater and more equitable access to medicines.

 

Read more here: Pharmac's year in review leaves much to be desired